| __timestamp | Celldex Therapeutics, Inc. | Intra-Cellular Therapies, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 104381000 | 21226345 |
| Thursday, January 1, 2015 | 100171000 | 87718074 |
| Friday, January 1, 2016 | 102726000 | 93831530 |
| Sunday, January 1, 2017 | 96171000 | 79419009 |
| Monday, January 1, 2018 | 66449000 | 132166913 |
| Tuesday, January 1, 2019 | 42672000 | 89124838 |
| Wednesday, January 1, 2020 | 42534000 | 65782137 |
| Friday, January 1, 2021 | 53311000 | 88845513 |
| Saturday, January 1, 2022 | 82258000 | 134715000 |
| Sunday, January 1, 2023 | 118011000 | 180142000 |
Unleashing the power of data
In the competitive world of biotechnology, innovation is the lifeblood of success. Over the past decade, Intra-Cellular Therapies, Inc. and Celldex Therapeutics, Inc. have been at the forefront of this race, each investing heavily in research and development (R&D) to bring groundbreaking therapies to market. From 2014 to 2023, Intra-Cellular Therapies consistently increased its R&D spending, culminating in a 750% rise by 2023. In contrast, Celldex's investment fluctuated, peaking in 2014 and 2023, with a notable dip in 2019. By 2023, Intra-Cellular Therapies outspent Celldex by approximately 53%, highlighting its commitment to innovation. This trend underscores the strategic importance of sustained R&D investment in driving biotech advancements and maintaining a competitive edge. As these companies continue to innovate, their financial strategies offer valuable insights into the future of therapeutic development.
Comparing Innovation Spending: AbbVie Inc. and Intra-Cellular Therapies, Inc.
Analyzing R&D Budgets: Merck & Co., Inc. vs Celldex Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Amgen Inc. and Intra-Cellular Therapies, Inc.
Research and Development Investment: Amgen Inc. vs Celldex Therapeutics, Inc.
argenx SE or Celldex Therapeutics, Inc.: Who Invests More in Innovation?
R&D Spending Showdown: Viatris Inc. vs Intra-Cellular Therapies, Inc.
Comparing Innovation Spending: Viatris Inc. and Celldex Therapeutics, Inc.
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs ACADIA Pharmaceuticals Inc.
Who Prioritizes Innovation? R&D Spending Compared for Intra-Cellular Therapies, Inc. and Ligand Pharmaceuticals Incorporated
Research and Development Expenses Breakdown: Intra-Cellular Therapies, Inc. vs Amphastar Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: HUTCHMED (China) Limited vs Celldex Therapeutics, Inc.
Comparing Innovation Spending: Celldex Therapeutics, Inc. and MiMedx Group, Inc.